Astera Labs, INC Form 4 insider transactions
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. CEO Jitendra Mohan sold 18,264 shares of common stock across two days in July 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba has reported the sale of 92,991 shares of common stock across multiple transactions on July 2 and 3, 2025, executed under a Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCForm 4: Astera Labs Director Bethany Mayer Executes Pre-Planned Stock Sales and Family Trust Transfer
Astera Labs Director Bethany Mayer reported the sale of 686 shares of common stock under a Rule 10b5-1 trading plan and the transfer of 839 shares to a family trust.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. CEO Jitendra Mohan has sold 52,743 shares of common stock for approximately $5.32 million through a pre-scheduled Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director and 10% Owner Manuel Alba reported the sale of 20,150 shares of common stock on June 20, 2025, executed automatically under a Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs' President and COO, Sanjay Gajendra, sold 76,373 shares of common stock on June 18, 2025, through a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. CEO Jitendra Mohan sold 106,510 shares of common stock for approximately $10.07 million on June 17, 2025, as part of a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Stefan A Dyckerhoff was granted 2,351 restricted stock units, vesting over the next year, as part of the company's 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Manuel Alba was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Craig H. Barratt was granted 2,351 restricted stock units (RSUs) on June 8, 2025, aligning his interests with shareholders.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Michael E. Hurlston was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Jack R. Lazar was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. Director Bethany Mayer was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs' President and COO, Sanjay Gajendra, sold 88,627 shares of common stock for approximately $8.7 million on June 4, 2025, through a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs' Chief Financial Officer, Michael Truett Tate, sold 499,000 shares of common stock on May 30, 2025, through a pre-arranged 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba sold 600 shares of common stock for $100 per share on May 29, 2025, as part of a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. CEO and Director Jitendra Mohan reported the sale of 14,200 shares of common stock for approximately $1.42 million, executed automatically under a Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs' President and COO, Sanjay Gajendra, sold 165,000 shares of common stock for approximately $16.2 million through a pre-established Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 106,875 shares of common stock on May 19, 2025, at an average price of $90.0195, pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCSanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
ALAB
Astera Labs, INCPhilip Mazzara, General Counsel and Secretary of Astera Labs, sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CFO Michael Truett Tate sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
ALAB
Astera Labs, INCDirector Michael Hurlston of Astera Labs, Inc. executed multiple sales of common stock on May 15, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCPhilip Mazzara, General Counsel and Secretary of Astera Labs, acquired 196 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 75,000 shares of common stock at a price of $90.9032 per share on May 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCSanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on May 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 87,500 shares of common stock on May 8, 2025, for approximately $71.05 per share, totaling around $4.26 million, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCDirector Manuel Alba sold shares of Astera Labs (ALAB) on April 2nd and 3rd, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
ALAB
Astera Labs, INCAstera Labs CEO Jitendra Mohan sold 75,000 shares of common stock on March 3, 2025, at a weighted average price of $71.3688, pursuant to a pre-arranged Rule 10b5-1 trading plan.